Defining and measuring suspicion of sepsis: an analysis of routine data

被引:24
作者
Inada-Kim, Matthew [1 ]
Page, Bethan [2 ]
Maqsood, Imran [3 ]
Vincent, Charles [2 ]
机构
[1] Hampshire Hosp NHS Fdn Trust, Royal Hampshire Cty Hosp, Winchester, Hants, England
[2] Univ Oxford, Dept Expt Psychol, Oxford, England
[3] Oxford Sci Pk, Oxford Acad Hlth Sci Network, Magdalen Ctr, Oxford, England
关键词
SEPTIC SHOCK; CARE; EPIDEMIOLOGY; MORTALITY; TRENDS;
D O I
10.1136/bmjopen-2016-014885
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives To define the target population of patients who have suspicion of sepsis (SOS) and to provide a basis for assessing the burden of SOS, and the evaluation of sepsis guidelines and improvement programmes. Design Retrospective analysis of routinely collected hospital administrative data. Setting Secondary care, eight National Health Service (NHS) Acute Trusts. Participants Hospital Episode Statistics data for 20132014 was used to identify all admissions with a primary diagnosis listed in the 'suspicion of sepsis' ( SOS) coding set. The SOS coding set consists of all bacterial infective diagnoses. Results We identified 47 475 admissions with SOS, equivalent to a rate of 17 admissions per 1000 adults in a given year. The mortality for this group was 7.2% during their acute hospital admission. Urinary tract infection was the most common diagnosis and lobar pneumonia was associated with the most deaths. A short list of 10 diagnoses can account for 85% of the deaths. Conclusions Patients with SOS can be identified in routine administrative data. It is these patients who should be screened for sepsis and are the target of programmes to improve the detection and treatment of sepsis. The effectiveness of such programmes can be evaluated by examining the outcomes of patients with SOS.
引用
收藏
页数:7
相关论文
共 27 条
[1]
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study [J].
Alberti, C ;
Brun-Buisson, C ;
Burchardi, H ;
Martin, C ;
Goodman, S ;
Artigas, A ;
Sicignano, A ;
Palazzo, M ;
Moreno, R ;
Boulmé, R ;
Lepage, E ;
Le Gall, JR .
INTENSIVE CARE MEDICINE, 2002, 28 (02) :108-121
[2]
[Anonymous], NATL INPATIENT HOSP
[3]
[Anonymous], NATL VITAL STAT REPO
[4]
[Anonymous], CRIT CARE MED
[5]
[Anonymous], IMPR OUTC PAT SEPS
[6]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[7]
Sepsis: a roadmap for future research [J].
Cohen, Jonathan ;
Vincent, Jean-Louis ;
Adhikari, Neill K. J. ;
Machado, Flavia R. ;
Angus, Derek C. ;
Calandra, Thierry ;
Jaton, Katia ;
Giulieri, Stefano ;
Delaloye, Julie ;
Opal, Steven ;
Tracey, Kevin ;
van der Poll, Tom ;
Pelfrene, Eric .
LANCET INFECTIOUS DISEASES, 2015, 15 (05) :581-614
[8]
Epidemiology of sepsis: Recent advances [J].
Danai P. ;
Martin G.S. .
Current Infectious Disease Reports, 2005, 7 (5) :329-334
[9]
Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]
[10]
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003 [J].
Dombrovskiy, Viktor Y. ;
Martin, Andrew A. ;
Sunderram, Jagadeeshan ;
Paz, Harold L. .
CRITICAL CARE MEDICINE, 2007, 35 (05) :1244-1250